Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Astria Therapeutics, Inc. logo — company profile

Astria Therapeutics, Inc.

Founded 2008 United States Boston, United States 95 employees Post Ipo Equity Total: $546.31M Biopharma, Biotechnology +1

General Information

Company Name Astria Therapeutics, Inc.
Founded Year 2008
Location United States Boston, United States +1
Founders / Decision Makers
Team member
Employees 95
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Astria Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Astria Therapeutics, Inc.

Astria Therapeutics, Inc. is a biopharmaceutical company founded in 2008 and based in the United States. Specializing in Hereditary Angioedema (HAE) and rare allergic and immunological diseases, the company's mission is to bring life-changing therapies to patients and families. The company's last investment of $125.00MPost-IPO Equity investment on 30 January 2024 garnered support from prominent investors including RA Capital Management, Adage Capital Management, Driehaus Capital Management, Perceptive Advisors, TCG Crossover, and Venrock Healthcare Capital Partners. The Astria Therapeutics, Inc. team is driven by a patient-centric approach, with a focus on developing therapies that have the potential to significantly improve the quality of life for those affected by these diseases. The company's dedication to its cause is reflected in its name, which is derived from the Greek word for star, symbolizing the guiding influence of patients in their therapeutic development. For more information about the company and its innovative therapies, interested parties can visit www.astriatx.com. With its strong investor backing and commitment to addressing critical unmet medical needs, Astria Therapeutics, Inc. stands poised to make a substantial impact in the healthcare and biopharmaceutical industries.

Taxonomy: Therapeutics, Hereditary Angioedema, Rare Diseases, Immunological Diseases, Patient-centric, Life-changing Therapies, Medical Research, Healthcare Innovation, Patient Advocacy

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 6
Investor Investor Investor Investor Investor Investor
30 Jan 2024
Post-IPO Equity •••••• - 11 Oct 2023
Post-IPO Equity •••••• - 15 Dec 2022
Post-IPO Equity •••••• - 29 Jan 2020
Post-IPO Equity •••••• - 01 Nov 2018

View All 15 Funding Rounds

Astria Therapeutics, Inc. Alternatives & Competitors

Astria Therapeutics, Inc. vs
Alumis
Alumis United States

Transforming the lives of patients living with immune-mediated diseases using a precision approach.

Series C
249 employees
Biotechnology, Health Care
Compare Astria Therapeutics, Inc. vs Alumis
Astria Therapeutics, Inc. vs
Evommune
Evommune United States

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

Unknown
69 employees
Biotechnology, Health Care
Compare Astria Therapeutics, Inc. vs Evommune
Astria Therapeutics, Inc. vs
Harmony Biosciences
Harmony Biosciences United States

A fresh approach to helping patients thrive.

Post Ipo Debt
273 employees
Biopharma, Biotechnology
Compare Astria Therapeutics, Inc. vs Harmony Biosciences

FAQ About Astria Therapeutics, Inc.

At Astria Therapeutics, our team is focused on bringing therapies with the potential to improve the quality of life to patients and families affected by Hereditary Angioedema (HAE) and rare allergic and immunological diseases. Our name originates from the Greek word for star, and patients are guid...
Astria Therapeutics, Inc. was founded in 2008.
Astria Therapeutics, Inc. is headquartered in Boston, United States.
Astria Therapeutics, Inc. operates in the following industries: Biopharma, Biotechnology, Health Care.
Astria Therapeutics, Inc. has approximately 95 employees.
Astria Therapeutics, Inc. has completed 15 funding rounds, raising a total of $546.31M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Astria Therapeutics, Inc. include Alumis, Evommune, Harmony Biosciences, Cerium Pharmaceuticals, Laboratorio Varifarma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Astria Therapeutics, Inc. and Alumis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Astria Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes